Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion type Assertion NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_head.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion description "[Thus, the use of synthetic inhibitors of miR-221 may prove to be a promising approach to liver cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion evidence source_evidence_literature NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion SIO_000772 20018759 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion wasDerivedFrom befree-2016 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.
- NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_assertion wasGeneratedBy ECO_0000203 NP782181.RA2-b2rEQ4ZDluKdDtTc7DpIGkA6aAx_-ILjIXSReUPpY130_provenance.